Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sotera Health CoSHC +1.80%74 EV-to-OCF is 26.99 as of Jul. 30, 2026, which is 9% above its 10-year median of 24.74. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.39 (Fairly Valued). The stock has 3 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Sotera Health Co ranks worse than 80.75% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Sotera Health Co's Enterprise Value is $7,046 Mil.
Sotera Health Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $261 Mil. Therefore, Sotera Health Co's EV-to-OCF for today is 26.99.
The historical rank and industry rank for Sotera Health Co's EV-to-OCF or its related term are showing as below:
SHC'
s EV-to-OCF Range Over the Past 10 Years
Min: -56.06 Med: 24.74 Max: 97.8
Current: 26.99
During the past 8 years, the highest EV-to-OCF of Sotera Health Co was 97.80. The lowest was -56.06. And the median was 24.74.
SHC's EV-to-OCF is ranked worse than 80.75% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.08
vs SHC: 26.99
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sotera Health Co's PE Ratio (TTM) for today is calculated as:
Sotera Health Co's share price for today is $17.85.
Sotera Health Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.410.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sotera Health Co EV-to-OCF Related Terms
Sotera Health Co EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Sotera Health Co's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Sotera Health Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotera Health Co EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Sotera Health Co's EV-to-OCF falls into.
Sotera Health Co's current Enterprise Value is $7,046 Mil.
Sotera Health Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $261 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotera Health Co (SHC) has a EV-to-OCF of 26.99 as of Jul. 30, 2026. This is near median its historical median of 24.74. According to the industry distribution chart, Sotera Health Co ranks #172 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 80.8%.
Is Sotera Health Co's EV-to-OCF too high?
Sotera Health Co's current EV-to-OCF of 26.99 is near median its 10-year median of 24.74. The Medical Diagnostics & Research industry median EV-to-OCF is 6.08. Sotera Health Co's value of 26.99 is 343.9% above this industry median. Based on the distribution chart, Sotera Health Co ranks #172 out of 213 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's EV-to-OCF compare to RDNT and VCYT?
According to the Medical Diagnostics & Research industry distribution chart, Sotera Health Co ranks #172 out of 213 companies for EV-to-OCF. This places Sotera Health Co in the lower half of its industry. The industry median EV-to-OCF is 6.08. Sotera Health Co's value of 26.99 is 343.9% above this benchmark. While the company's 10-year median is 24.74 vs. the industry median of 6.08, Sotera Health Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 6.08, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotera Health Co's current EV-to-OCF of 26.99 is 343.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotera Health Co's current EV-to-OCF is 26.99, which is near median its own 10-year median of 24.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.39, compared to a current price of $17.85 — trading 8.9% above its estimated fair value. The current EV-to-OCF is 26.99, which is near median its 10-year median of 24.74 and 343.9% above the Medical Diagnostics & Research industry median of 6.08. Sotera Health Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Sotera Health Co (SHC), the current EV-to-OCF is 26.99 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotera Health Co (SHC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued.
The current stock price of $17.85 is trading 8.9% above its estimated GF Value™ of $16.39.
GuruFocus considers Sotera Health Co to be Fairly Valued.
Key valuation signals for SHC:
EV-to-OCF: 26.99 (near median its 10-year median of 24.74)
GF Value™: $16.39 vs. price of $17.85 (8.9% above fair value)
Industry Position: 343.9% above the Medical Diagnostics & Research median (#172 of 213)
No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score
Get the complete analysis for SHC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHC has been successfully added to your 
